SINTX Technologies Inc Net Assets
SINTX Technologies Inc net assets. Based on the latest financial reports, SINTX Technologies Inc (SINT) has net assets worth $4.07 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.36 Million) and total liabilities ($7.30 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of SINTX Technologies Inc to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.07 Million |
| % of Total Assets | 35.8% |
| Annual Growth Rate | N/A |
| 5-Year Change | -84.91% |
| 10-Year Change | -72.64% |
| Growth Volatility | 132.4 |
Net Assets of SINTX Technologies Inc (2011–2024)
Net assets of SINTX Technologies Inc from 2011 to 2024. This chart illustrates how SINTX Technologies Inc's net assets have evolved over time, based on quarterly financial data. See SINT net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for SINTX Technologies Inc (2011–2024)
The table below shows the annual net assets of SINTX Technologies Inc from 2011 to 2024. For live market cap and overall valuation, see SINT company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $3.89 Million | -55.61% |
| 2023-12-31 | $8.77 Million | +53.79% |
| 2022-12-31 | $5.70 Million | -66.83% |
| 2021-12-31 | $17.20 Million | -33.36% |
| 2020-12-31 | $25.80 Million | +396.04% |
| 2019-12-31 | $5.20 Million | -38.06% |
| 2018-12-31 | $8.40 Million | +54.34% |
| 2017-12-31 | $5.44 Million | -62.14% |
| 2016-12-31 | $14.37 Million | +0.99% |
| 2015-12-31 | $14.23 Million | +106.05% |
| 2014-12-31 | $6.91 Million | +104.51% |
| 2013-12-31 | $-153.06 Million | -3.22% |
| 2012-12-31 | $-148.28 Million | -29.75% |
| 2011-12-31 | $-114.28 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to SINTX Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 18513590500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
SINTX Technologies Inc Net Assets Breakdown (December 2024)
SINTX Technologies Inc net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $13.00K | 0.33% |
| Other Components | $285.62 Million | 7334.85% |
| Total Equity | $3.89 Million | 100.00% |
SINTX Technologies Inc Competitors by Market Cap
The table below lists competitors of SINTX Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shanghai Taihe Water Environmental Technology Development Co Ltd
SHG:605081
|
$6.63 Million |
|
ChoA Pharmaceutical Co.Ltd
KQ:034940
|
$6.63 Million |
|
Silynxcom Ltd.
NYSE MKT:SYNX
|
$6.63 Million |
|
First Media Tbk
JK:KBLV
|
$6.64 Million |
|
Max Resource Corp
V:MAX
|
$6.63 Million |
|
Redsense Medical AB
ST:REDS
|
$6.62 Million |
|
RED LIGHT HOLLAND CORP.
F:4YX
|
$6.62 Million |
|
Pollen Street PLC
LSE:POLN
|
$6.61 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SINTX Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,772,000 to 3,894,000, a change of -4,878,000 (-55.6%).
- Net loss of 11,024,000 reduced equity.
- Other factors increased equity by 6,146,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.02 Million | -283.1% |
| Other Changes | $6.15 Million | +157.83% |
| Total Change | $- | -55.61% |
Book Value vs Market Value Analysis
This analysis compares SINTX Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.33x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | $-5194505.55 | $1.72 | x |
| 2012-12-31 | $-6740112.27 | $1.72 | x |
| 2013-12-31 | $-6957318.18 | $1.72 | x |
| 2014-12-31 | $143895.83 | $1.72 | x |
| 2015-12-31 | $63535.71 | $1.72 | x |
| 2016-12-31 | $218.34 | $1.72 | x |
| 2017-12-31 | $5480.53 | $1.72 | x |
| 2018-12-31 | $2188.07 | $1.72 | x |
| 2019-12-31 | $334.34 | $1.72 | x |
| 2020-12-31 | $147.91 | $1.72 | x |
| 2021-12-31 | $69.59 | $1.72 | x |
| 2022-12-31 | $17.98 | $1.72 | x |
| 2023-12-31 | $20.63 | $1.72 | x |
| 2024-12-31 | $5.23 | $1.72 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SINTX Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -283.10%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -884.75%
- • Asset Turnover: 0.13x
- • Equity Multiplier: 2.42x
- Recent ROE (-283.10%) is below the historical average (-130.27%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | -117.22% | 0.33x | 0.00x | $-12.32 Million |
| 2012 | 0.00% | -151.89% | 0.69x | 0.00x | $-20.21 Million |
| 2013 | 0.00% | -37.13% | 0.65x | 0.00x | $7.02 Million |
| 2014 | -471.72% | -143.12% | 0.48x | 6.89x | $-33.27 Million |
| 2015 | -168.02% | -122.92% | 0.53x | 2.56x | $-25.34 Million |
| 2016 | -147.73% | -109.01% | 0.58x | 2.34x | $-17.72 Million |
| 2017 | -171.43% | -83.09% | 0.77x | 2.69x | $-9.87 Million |
| 2018 | -103.01% | -9107.37% | 0.01x | 1.37x | $-9.49 Million |
| 2019 | -92.21% | -696.23% | 0.08x | 1.76x | $-5.32 Million |
| 2020 | -27.24% | -1183.33% | 0.02x | 1.18x | $-9.61 Million |
| 2021 | -54.14% | -1536.14% | 0.03x | 1.27x | $-11.03 Million |
| 2022 | -211.06% | -2003.16% | 0.04x | 2.77x | $-12.61 Million |
| 2023 | -94.15% | -314.39% | 0.17x | 1.75x | $-9.14 Million |
| 2024 | -283.10% | -884.75% | 0.13x | 2.42x | $-11.41 Million |
Industry Comparison
This section compares SINTX Technologies Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $296,528,539
- Average return on equity (ROE) among peers: -35.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SINTX Technologies Inc (SINT) | $4.07 Million | 0.00% | 1.79x | $6.63 Million |
| Abbott Laboratories (ABT) | $2.83 Billion | 34.08% | 0.96x | $190.23 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $2.34 Million |
| Aethlon Medical Inc (AEMD) | $-3.66 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-11.59 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $850.46 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $2.43 Million |
| Allurion Technologies, Inc. (ALUR) | $-77.98 Million | 0.00% | 0.00x | $21.01K |
| Autonomix Medical, Inc. Common Stock (AMIX) | $5.89 Million | -283.55% | 0.29x | $1.61 Million |
| Artivion Inc (AORT) | $276.20 Million | -4.84% | 1.86x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $14.18 Million | 18.92% | 0.18x | $109.52 Million |
About SINTX Technologies Inc
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composi… Read more